Please use this identifier to cite or link to this item: https://doi.org/10.3389/fpsyt.2020.621773
Title: Impact of SARS-CoV-2 Infection on Cognitive Function: A Systematic Review
Authors: Alnefeesi, Yazen
Siegel, Ashley
Lui, Leanna M. W.
Teopiz, Kayla M.
Ho, Roger C. M. 
Lee, Yena
Nasri, Flora
Gill, Hartej
Lin, Kangguang
Cao, Bing
Rosenblat, Joshua D.
McIntyre, Roger S.
Keywords: brain health
cognitive function
COVID-19
cytokines
delirium
depression
neuroinflammation
neurotropism
Issue Date: 10-Feb-2021
Publisher: Frontiers Media S.A.
Citation: Alnefeesi, Yazen, Siegel, Ashley, Lui, Leanna M. W., Teopiz, Kayla M., Ho, Roger C. M., Lee, Yena, Nasri, Flora, Gill, Hartej, Lin, Kangguang, Cao, Bing, Rosenblat, Joshua D., McIntyre, Roger S. (2021-02-10). Impact of SARS-CoV-2 Infection on Cognitive Function: A Systematic Review. Frontiers in Psychiatry 11 : 621773. ScholarBank@NUS Repository. https://doi.org/10.3389/fpsyt.2020.621773
Rights: Attribution 4.0 International
Abstract: The prevalence and etiology of COVID-19's impact on brain health and cognitive function is poorly characterized. With mounting reports of delirium, systemic inflammation, and evidence of neurotropism, a statement on cognitive impairment among COVID-19 cases is needed. A substantial literature has demonstrated that inflammation can severely disrupt brain function, suggesting an immune response, a cytokine storm, as a possible cause of neurocognitive impairments. In this light, the aim of the present study was to summarize the available knowledge of the impact of COVID-19 on cognition (i.e., herein, we broadly define cognition reflecting the reporting on this topic in the literature) during the acute and recovery phases of the disease, in hospitalized patients and outpatients with confirmed COVID-19 status. A systematic review of the literature identified six studies which document the prevalence of cognitive impairment, and one which quantifies deficits after recovery. Pooling the samples of the included studies (total sample n = 644) at three standards of quality produced conservative estimates of cognitive impairment ranging from 43.0 to 66.8% prevalence in hospitalized COVID-19 patients only, as no studies which report on outpatients met criteria for inclusion in the main synthesis. The most common impairment reported was delirium and frequent reports of elevated inflammatory markers suggest etiology. Other studies have demonstrated that the disease involves marked increases in IL-6, TNF?, and IL-1?; cytokines known to have a profound impact on working memory and attention. Impairment of these cognitive functions is a characteristic aspect of delirium, which suggests these cytokines as key mediators in the etiology of COVID-19 induced cognitive impairments. Researchers are encouraged to assay inflammatory markers to determine the potential role of inflammation in mediating the disturbance of cognitive function in individuals affected by COVID-19. © Copyright © 2021 Alnefeesi, Siegel, Lui, Teopiz, Ho, Lee, Nasri, Gill, Lin, Cao, Rosenblat and McIntyre.
Source Title: Frontiers in Psychiatry
URI: https://scholarbank.nus.edu.sg/handle/10635/232515
ISSN: 1664-0640
DOI: 10.3389/fpsyt.2020.621773
Rights: Attribution 4.0 International
Appears in Collections:Elements
Staff Publications

Show full item record
Files in This Item:
File Description SizeFormatAccess SettingsVersion 
10_3389_fpsyt_2020_621773.pdf3.86 MBAdobe PDF

OPEN

NoneView/Download

Google ScholarTM

Check

Altmetric


This item is licensed under a Creative Commons License Creative Commons